This topic contains a solution. Click here to go to the answer

Author Question: A _________ in an intermediary that provides connectivity and transport of cloud services from CP's ... (Read 121 times)

WWatsford

  • Hero Member
  • *****
  • Posts: 539
    • Biology Forums!
A _________ in an intermediary that provides connectivity and transport of cloud services from CP's to cloud consumers.
 
  What will be an ideal response?

Question 2

Appropriate use of icons on the screen allows contrast of foreground and background.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

wuly

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

cloud carrier

Answer to Question 2

FALSE




WWatsford

  • Member
  • Posts: 539
Reply 2 on: Jul 7, 2018
:D TYSM


flexer1n1

  • Member
  • Posts: 373
Reply 3 on: Yesterday
Gracias!

 

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Many people have small pouches in their colons that bulge outward through weak spots. Each pouch is called a diverticulum. About 10% of Americans older than age 40 years have diverticulosis, which, when the pouches become infected or inflamed, is called diverticulitis. The main cause of diverticular disease is a low-fiber diet.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library